Clinical Trial Update: Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

View source ↗

Summary

Completion update for a clinical trial evaluating exosome-based detection of molecular residual disease in stage II-III colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Colo-rectal Cancer, Colorectal Cancer Recurrent | Status: COMPLETED